Wealth Management Partners LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 45.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,242 shares of the healthcare conglomerate's stock after purchasing an additional 1,008 shares during the period. Wealth Management Partners LLC's holdings in UnitedHealth Group were worth $985,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares during the period. Wellington Management Group LLP grew its holdings in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares during the period. GAMMA Investing LLC grew its holdings in UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after acquiring an additional 8,280,404 shares during the period. Bank of New York Mellon Corp grew its holdings in UnitedHealth Group by 2.5% during the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock worth $4,257,131,000 after acquiring an additional 196,696 shares during the period. Finally, Nuveen LLC acquired a new position in UnitedHealth Group during the first quarter worth $3,846,764,000. Institutional investors and hedge funds own 87.86% of the company's stock.
UnitedHealth Group Stock Performance
Shares of UNH traded up $6.12 during mid-day trading on Tuesday, hitting $347.42. The stock had a trading volume of 9,773,475 shares, compared to its average volume of 12,991,036. The company has a market cap of $314.65 billion, a PE ratio of 15.06, a PEG ratio of 2.20 and a beta of 0.44. The company's fifty day simple moving average is $296.49 and its two-hundred day simple moving average is $362.50. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group's revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.
Analysts Set New Price Targets
Several research firms have weighed in on UNH. Bank of America upped their target price on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a report on Monday, August 18th. Piper Sandler lowered their target price on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Morgan Stanley upped their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an "overweight" rating in a report on Friday, September 12th. Cantor Fitzgerald reissued an "overweight" rating and issued a $440.00 target price on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, JPMorgan Chase & Co. reduced their price objective on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 6th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $358.95.
Get Our Latest Stock Analysis on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.